Australia markets open in 2 hours 55 minutes

Crinetics Pharmaceuticals, Inc. (CRNX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
50.40-1.84 (-3.52%)
At close: 04:00PM EDT
51.38 +0.98 (+1.94%)
After hours: 05:05PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close52.24
Open52.00
Bid50.33 x 100
Ask50.42 x 100
Day's range49.93 - 52.26
52-week range25.35 - 55.78
Volume624,696
Avg. volume760,316
Market cap4.034B
Beta (5Y monthly)0.64
PE ratio (TTM)N/A
EPS (TTM)-3.76
Earnings date05 Nov 2024 - 11 Nov 2024
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est70.38
  • GlobeNewswire

    Crinetics Pharmaceuticals Announces September 2024 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

    SAN DIEGO, Sept. 10, 2024 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that on September 10, 2024, the Compensation Committee of Crinetics’ Board of Directors granted non-qualified stock option awards to purchase an aggregate of 120,200 shares of its common stock to fifteen new non-executive employees under the Crinetics Pharmaceuticals, Inc. 2021 Employment Inducement Incentive Award Plan (the “2021 Inducement Plan”). The stock options were granted as induc

  • Insider Monkey

    Crinetics Pharmaceuticals, Inc. (CRNX): Among the Best Mid-Cap Healthcare Stocks To Buy Now

    We recently compiled a list of the 10 Best Mid-Cap Healthcare Stocks To Buy Now. In this article, we are going to take a look at where Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) stands against the other mid-cap healthcare stocks. Global Healthcare Market: Growth Projections, Challenges, and Tech-Driven Innovations According to projections by ReportLinker, the market for healthcare […]

  • GlobeNewswire

    Crinetics Pharmaceuticals to Participate in Two Upcoming Investor Conferences

    SAN DIEGO, Aug. 29, 2024 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), a clinical stage pharmaceutical company focused on the discovery, development and commercialization of novel therapeutics for endocrine diseases and endocrine-related tumors, today announced that company management will participate in fireside chats at the Morgan Stanley 22nd Annual Global Healthcare Conference and the Cantor Global Healthcare Conference both being held in New York, NY in September. Morg